In Vivo Cardioprotection by N-Acetylcysteine and Isosorbide 5-Mononitrate in a Rat Model of Ischemia-Reperfusion

Cardiovascular Drugs and Therapy

Volumn 17, Issue 3, 2003, Pages 199-208

  Calvillo, Laura ^a   Masson, Serge ^a   Salio, Monica ^a   Pollicino, Loredana ^a   De Angelis, Noeleen ^a   Fiordaliso, Fabio ^a   Bai, Antonio ^a   Ghezzi, Pietro ^a   Santangelo, Francesco ^b   Latini, Roberto ^a  

^a Ist Ric Farmacologiche Mario Negri ^*  (Italy)

^b Zambon Group SpA   (Italy)

Author keywords

Antioxidant; Heart; Infarct size; Ischemia reperfusion injury; Isosorbide 5 mononitrate; N acetylcysteine; Rat

Indexed keywords

ACETYLCYSTEINE; DRUG VEHICLE; ISOSORBIDE 5 NITRATE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG INFUSION; DRUG SCREENING; HEART INFARCTION SIZE; HEART LEFT VENTRICLE; HEART LEFT VENTRICLE ENDDIASTOLIC PRESSURE; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; HEART PROTECTION; HEART STRESS; IN VIVO STUDY; MACROPHAGE; MALE; MONOCYTE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PRIORITY JOURNAL; RAT; REPERFUSION INJURY;

ACETYLCYSTEINE; ANIMALS; BLOOD PRESSURE; DRUG THERAPY, COMBINATION; FREE RADICAL SCAVENGERS; ISOSORBIDE DINITRATE; MALE; MONOCYTES; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION INJURY; NEUTROPHILS; NITRIC OXIDE DONORS; RATS; RATS, SPRAGUE-DAWLEY;

EID: 10744228762     PISSN: 09203206     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1026182404805     Document Type: Article

References (53)

1. Verma S, Fedak PWM, Weisel RD, et al. Fundamentals of reperfusion injury for the clinical cardiologist. Circulation 2002;105:2332-2336.
2. Hearse DJ, Humphrey SM, Chain EB. Abrupt reoxygenation of the anoxic potassium-arrested perfused rat heart: A study of myocardial enzyme release. J Molec Cell Cardiol 1973;5:395-407.
3. Kaplan P, Lehotsky J, Racay P. Role of sarcoplasmic reticulum in the contractile dysfunction during myocardial ischemia and reperfusion. Physiol Res 1997;46:333-339.
4. Bolli R, Jeroudi MO, Patel BS, et al. Direct evidence that oxygen-derived free radicals contribute to postischemic myocardial dysfunction in the intact dog. Proc Natl Acad Sci (USA) 1989;86:4695-4699.
5. Dhalla NS, Elmoselhi AB, Hata T, Makino N. Status of myocardial antioxidants in ischemia-reperfusion injury. Cardiovasc Res 2000;47:446-456.
6. Lesnefsky EJ, Dauber IM, Horwitz LD. Myocardial sulfhydryl pool alterations during reperfusion after brief and prolonged myocardial ischemia in vivo. Circ Res 1991; 68:605-613.
7. Ramires PR, Ji LL. Glutathione supplementation and training increases myocardial resistance to ischemia-reperfusion in vivo. Am J Physiol 2001;281:H679-H688.
8. Sochman J, Kolc J, Vrana M, Fabian J. Cardioprotective effects of N-acetylcysteine: The reduction in the extent of infarction and occurrence of reperfusion arrhythmias in the dog. Int J Cardiol 1990;28:191-196.
9. Aruoma OI, Halliwell B, Hoey BM, Butler J. The antioxidant action of N-acetylcysteine: Its reaction with hydrogen peroxide, hydroxyl radical, superoxide, and hypochlorous acid. Free Radic Biol Med 1989;6:593-597.
10. Horowitz JD, Antman EM, Lorell BH, Barry WH, Smith TW. Potentiation of the cardiovascular effects of nitroglycerin by N-acetylcysteine. Circulation 1983;68:1247-1253.
11. Mehara A, Shotan A, Ostrzega E, Hsueh W, Vasquez-Johnson J, Elkayam U. Potentiation of isosorbide dinitrate effects with N-acetylcysteine in patients with chronic heart failure. Circulation 1994;89:2595-2600.
12. Arstall MA, Yang J, Stafford I, Betts WH, Horowitz JD. N-acetylcysteine in combination with nitroglycerin and streptokinase for the treatment of evolving acute myocardial infarction. Circulation 1995;92:2855-2862.
13. Ardissino D, Merlini PA, Savonitto S, et al. Effect of transdermal nitroglycerin or N-acetylcysteine, or both, in the long-term treatment of unstable angina pectoris. J Am Coll Cardiol 1997;29:941-947.
14. Ignarro LJ, Lippton H, Edwards JC, et al. Mechanism of vascular smooth muscle relaxation by organic nitrates, nitrites, nitroprusside and nitric oxide: Evidence for the involvement of S-nitrosothiols as active intermediates. J Pharmacol Exp Ther 1981;218:739-749.
15. Loscalzo J. N-acetylcysteine potentiates inhibition of platelet aggregation by nitroglycerin. J Clin Invest 1985;76: 703-708.
16. Stamler J, Mendelsohn ME, Amarante P, et al. N-acetylcysteine potentiates platelet inhibition by endothelium-derived relaxing factor. Circ Res 1989;65:789-795.
17. Cooke JP, Stamler J, Andon N, Davies PF, McKinley G, Loscalzo J. Flow stimulates endothelial cells to release a nitrovasodilator that is potentiated by reduced thiol. Am J Physiol 1990;259:H804-H812.
18. Scharfstein JS, Keany JF, Jr, Slivka A, et al. In vivo transfer of nitric oxide between a plasma protein-bound reservoir and low molecular weight thiols. J Clin Invest 1994;94:1432-1439.
19. Elkayam U. Tolerance to organic nitrates: Evidences, mechanisms, clinical relevance and strategies for prevention. Ann Intern Med 1991;14:667-677.
20. Parker JO, Farrel B, Lahey KA, Rose BF. Nitrate tolerance: The lack of effect of N-acetylcysteine. Circulation 1987;76:572-576.
21. Forman MB, Puett DW, Cates CU, et al. Glutathione redox pathway and reperfusion injury. Effect of N-acetylcysteine on infarct size and ventricular function. Circulation 1988;78:202-213.
22. Tripathi Y, Hedge BM. Effect of N-acetylcysteine on myocardial infarct size and reperfusion in dogs. Indian J Physiol Pharmacol 1998;42:50-56.
23. Kingma JG, Jr, Rouleau JL. Effect of N-acetylcysteine on tissue necrosis during acute myocardial infarction in rabbits. Can J Cardiol 1989;5:321-326.
24. Alberola A, Such L, Gil F, Zaragoza R, Morcillo EJ. Protective effect of N-acetylcysteine on ischaemia-induced myocardial damage in canine heart. Naunyn-Schmiederberg's Arch Pharmacol 1991;343:505-510.
25. Jugdutt B. Myocardial salvage by intravenous nitroglycerin in conscious dogs: Loss of beneficial effect with marked nitroglycerin-induced hypotension. Circulation 1983;68: 673-684.
26. Chiariello M, Brevetti G, Ambrosio G, Cataffo A, Pollice U, Condorelli M. Long-term protection of ischemic myocardium by nitroglycerin ointment. Cardiovasc Res 1984;8:321-325.
27. Anversa P, Beghi C, Kikkawa Y, Olivetti G. Myocardial response to infarction in the rat. Morphometric measurement of infarct size and myocyte cellular hypertrophy. Am J Pathol 1985;18:484-492.
28. Davreux CJ, Soric I, Nathens AB, et al. N-acetyl cysteine attenuates acute lung injury in the rat. Shock 1997;8:432-438.
29. Schmidt W, Walther A, Gebhard MM, Martin E, Schmidt H. Influence of N-acetylcysteine treatment on endotoxin-induced microcirculatory disturbances. Intensive Care Med 1998;24:967-972.
30. Victor VM, Guayerbas N, Garrotte M, Del Rio M, De La Fuente M. Modulation of murine macrophage function by N-acetylcysteine in a model of endotoxic shock. BioFactors 1999;10:347-357.
31. Cuzzocrea S, Mazzon E, Costantino G, Serraino I, De Sarro A, Caputi A. Effects of N-acetylcysteine in a rat model of ischemia and reperfusion injury. Cardiovasc Res 2000;47:537-548.
32. Riva E, Kurosaki M, Porzio S, Latini R, Lagrasta C, Olivetti G. Effects of an early treatment with lisinopril and isosorbide-5-mononitrate on hemodynamics and late ventricular remodelling in rats with 9-week myocardial infarction. Cardioscience 1995;6:139-146.
33. Hansen PR. Role of neutrophils in myocardial ischemia and reperfusion. Circulation 1995;91:1872-1885.
34. Latini R, Masson S, Bertini R, Maggioni AP, Ghezzi P, Calvillo L. Cardiac protection by pharmacological modulation of inflammation. Expert Opin Investig Drugs 2001; 10:1913-1924.
35. Weber C, Erl W, Pietsch A, Strobel M, Ziegler-Heitbrock HW, Weber PC. Antioxidants inhibit monocyte adhesion by suppressing nuclear factor-kappa B mobilization and induction of vascular cell adhesion molecule-1 in endothelial cells stimulated to generate radicals. Arterioscler Thromb 1994;4:1665-1673.
36. Schmidt H, Schmidt W, Muller T, Bohrer H, Gebhard MM, Martin E. N-acetylcysteine attenuates endotoxin-induced leukocyte-endothelial cell adhesion and macromolecular leakage in vivo. Crit Care Med 1997;25:858-863.
37. Ghezzi P, Dinarello CA, Bianchi M, Rosandich ME, Repine JE, White CW. Hypoxia increases production of interleukin-1 and tumor necrosis factor by human mononuclear cells. Cytokine 1991;3:189-194.
38. Peristeris P, Clark BD, Gatti S, et al. N-acetylcysteine and glutathione as inhibitors of tumor necrosis factor production. Cell Immunol 1992;40:390-399.
39. Leff JA, Wilke CP, Hybertson BM, Shanley PF, Beehler CJ, Repine JE. Postinsult treatment with N-acetyl-L-cysteine decreases IL-1-induced neutrophil influx and lung leak in rats. Am J Physiol 1993;265:L501-L506.
40. Sato M, Miyazaki T, Nagaya T, et al. Antioxidants inhibit tumor necrosis factor-alpha mediated stimulation of interleukin-8, monocyte chemoattractant protein-1, and collagenase expression in cultured human synovial cells. J Rheumatol 1996;23:432-438.
41. Schreck R, Rieber P, Baeuerle PA. Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-kappa B transcription factor and HIV-1. EMBO J 1991;10:2247-2258.
42. Cargnoni A, Ceconio C, Gaia G, Agnoletti L, Ferrari R. Cellular thiols redox status: A switch for NF-kB activation during myocardial post-ischaemic reperfusion. J Molec Cell Cardiol 2002;34:997-1005.
43. Marui N, Offermann MK, Swerlick R, et al. Vascular cell adhesion molecule-1 (VCAM-1) gene transcription and expression are regulated through an antioxidant-sensitive mechanism in human vascular endothelial cells. J Clin Invest 1993;92:1866-1874.
44. Maekawa N, Wada H, Kanda T, et al. Improved myocardial ischemia/reperfusion injury in mice lacking tumor necrosis factor-alpha. J Am Coll Cardiol 2002;39:1229-1235.
45. Sargent CA, Sleph PG, Dzwnczyk S, et al. Cardioprotection in ischemic rat hearts with SH-containing angiotensin-converting enzyme inhibitor zofenopril: Possible involvement of the ATP-sensitive potassium channel. J Pharmacol Exp Ther 1993;265:609-618.
46. Buikema H, Monnink SHJ, Tio RA, Crijns HJGM, De Zeeuw D, Van Gilst WH. Comparison of zofenopril and lisinopril to study the role of the sulfhydryl-group in improvement of endothelial dysfunction with ACE-inhibitors in experimental heart failure. Br J Pharmacol 2000;30:1999-2007.
47. Andrews NP, Prassad A, Quyyumi AA. N-acetylcysteine improves coronary and peripheral vascular function. J Am Coll Cardiol 2001;37:117-123.
48. Daemen MA, van't Veer C, Denecker G, et al. Inhibition of apoptosis induced by ischemia-reperfusion prevents inflammation. J Clin Invest 1999;104:541-549.
49. Rabuffetti M, Sciorati C, Tarozzo G, Clementi E, Manfredi AA, Beltramo M. Inhibition of caspase-1-like activity by Ac-Tyr-Val-Ala-Asp-chloromethyl ketone induces long-lasting neuroprotection in cerebral ischemia through apoptosis reduction and decrease of proinflammatory cytokines. J Neurosci 2000;20:4398-4404.
50. Inserte J, Taimor G, Hofstaetter B, Garcia-Dorado D, Piper HM. Influence of simulated ischemia on apoptosis induction by oxidative stress in adult cardiomyocytes of rats. Am J Physiol 2000;278:H94-H99.
51. Yamamoto S, Seta K, Morisco C, Vatner SF, Sadoshima J. Chelerythrine rapidly induces apoptosis through generation of reactive oxygen species in cardiac myocytes. J Molec Cell Cardiol 2001;33:1829-1848.
52. Mannisi JA, Weisman HF, Bush DE, Dudeck P, Healy B. Steroid administration after myocardial infarction promotes early infarct expansion. J Clin Invest 1987;79:1431-1439.
53. Galie N, Guarnieri C, Ussia GP, et al. Limitation of myocardial infarct size by nicorandil after sustained ischemia in pigs. Br J Pharmacol 1995;26:477-484.